To investigate whether the PS-5 mimetic affects the migratory property of T lymphocytes, we analyzed the ability

of T-cell populations to respond to supernatants from IFN-γ-activated keratinocytes in transwell migration assays. As shown in Figure 5A, supernatants from untreated or NC-treated-keratinocytes stimulated Sorafenib concentration with IFN-γ were fourfold more efficient in eliciting migratory responses of circulating PBMCs previously stained for anti-CD3, compared with supernatants from unstimulated strains. On the contrary, the treatment with PS-5, as well as with KIR peptide, significantly reduced the IFN-γ-dependent migration of PBMCs toward the supernatants of activated keratinocytes. Similar effects were observed in migration experiments performed with skin T-cell lines derived from type 1-mediated inflammatory skin diseases, including psoriasis (Fig. 5B) and lichen planus (Fig. 5C). Finally, we investigated the effects of PS-5 peptide on STAT1 activation and the expression of STAT1-dependent inflammatory genes in organ cultures of normal human skin treated with IFN-γ. As shown in Figure 6, the explants of IFN-γ-treated skin preincubated with PS-5, as well as with KIR peptide, showed a faint epidermal immunoreactivity for phosphorylated STAT1, compared with those observed in skin explants treated with NC peptide or its vehicle (Fig. 6). In these skin explants, phospho-STAT1 expression

BAY 80-6946 order was comparable with that observed in abundance in lesional skin obtained from psoriatic patients, used as positive control. In contrast, phospho-STAT1 staining was quite absent in untreated skin explants and in uninvolved zones (nonlesional skin) of psoriatic plaques. As direct consequence of the reduced STAT1 phosphorylation and activation, the Edoxaban epidermal expression of ICAM-1, HLA-DR, CXCL10 was abrogated in IFN-γ-treated explants of human skin incubated with PS-5 or KIR mimetics, compared with that found in organ cultures treated with NC peptide or vehicle (Fig. 7). The decrease of the number of ICAM-1+,

HLA-DR+, or CXCL10+ epidermal cells in PS-5-treated skin organ cultures was highly significant, as demonstrated by counting positive cells/mm2 in four different stained sections obtained from three skin explants for each condition (Fig. 7). Taken together, these results highlighted the efficiency of PS-5 mimetic to dampen the inflammatory responses triggered by JAK2/STAT1 signaling in human skin. Inhibition of JAK2 activity and the consequent inactivation of the downstream STAT1 transcription factor represent a promising strategy for the attenuation of the inflammatory responses elicited by epidermal keratinocytes following massive exposure to IFN-γ in the skin. In recent years, a number of small molecule inhibitors of IFN-γ signaling have been developed, including mimetics sharing the KIR region of SOCS1 protein [12, 22, 23].